Nawrocki Pawel, Szwedo Ireneusz, Tyc Joanna, Hawrysz Anna, Janiak Kamila, Cichoń Romuald
Department of Cardiac Surgery, Wroclaw Medical University, Wroclaw, Poland.
Lower Silesian Centre for Heart Diseases MEDINET, Wroclaw, Poland.
Kardiochir Torakochirurgia Pol. 2015 Sep;12(3):195-8. doi: 10.5114/kitp.2015.54454. Epub 2015 Sep 28.
Acute renal failure (ARF) is a rare (2-15%), but severe complication of cardiac surgery with overall mortality reaching 40-80%. In order to save patients' lives they are treated with renal replacement therapy (RRT). The aim of our study was to assess the impact of different perioperative factors on mortality among patients treated with RRT because of acute renal failure, which occurred as a complication of a heart surgery.
Retrospective analysis included 45 patients, operated in the years 2009-2013, who underwent renal replacement therapy in order to treat postoperative ARF. The perioperative factors were analysed in two groups: group 1 - patients who died before discharge; and group 2 - those who survived until hospital discharge.
Forty-five of 3509 cardiac surgical patients (1.25%) required RRT after the surgery. A total of 23 (51.11%) died before discharge (group 1). Patients in group 1 were characterised by older age (70.21 vs. 67 years), higher mean EuroSCORE value (9.28 vs. 7.15) (p < 0.05), higher percentage of concomitant surgery (63.63% vs. 28.57%) (p < 0.05) and of admission of catecholamines in the postoperative period (100% vs. 68.42%) (p < 0.005), and higher mean urea blood level prior to RRT initiation (156.65 vs. 102.54 mg/dl) (p < 0.05).
The statistically relevant death predictors proved to be: high EuroSCORE, concomitant surgery, and high urea level at RRT initiation and admission of catecholamines in the postoperative period. After conformation in further studies, those factors may prove useful in stratification of death risk among surgical patients requiring RRT.
急性肾衰竭(ARF)是心脏手术中一种罕见(2%-15%)但严重的并发症,总体死亡率达40%-80%。为挽救患者生命,会对其进行肾脏替代治疗(RRT)。我们研究的目的是评估不同围手术期因素对因心脏手术并发症导致急性肾衰竭而接受RRT治疗的患者死亡率的影响。
回顾性分析纳入了2009年至2013年间接受手术且因术后ARF接受肾脏替代治疗的45例患者。围手术期因素在两组中进行分析:第1组为出院前死亡的患者;第2组为存活至出院的患者。
3509例心脏手术患者中有45例(1.25%)术后需要RRT。共有23例(51.11%)在出院前死亡(第1组)。第1组患者的特点是年龄较大(70.21岁对67岁)、欧洲心脏手术风险评估系统(EuroSCORE)平均分值较高(9.28对7.15)(p<0.05)、同期手术的比例较高(63.63%对28.57%)(p<0.05)、术后接受儿茶酚胺治疗的比例较高(100%对68.42%)(p<0.005),以及开始RRT前平均血尿素水平较高(156.65对102.54mg/dl)(p<0.05)。
经统计学验证的死亡预测因素为:高EuroSCORE分值、同期手术、开始RRT时的高尿素水平以及术后接受儿茶酚胺治疗。在进一步研究证实后,这些因素可能有助于对需要RRT的手术患者进行死亡风险分层。